Picton Mahoney Asset Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-15,950
| Closed | -$504K | – | 467 |
|
|
2023
Q3 | $504K | Buy |
15,950
+24
| +0.2% | +$758 | 0.02% | 221 |
|
|
2023
Q2 | $649K | Buy |
15,926
+16
| +0.1% | +$652 | 0.03% | 239 |
|
|
2023
Q1 | $593K | Buy |
15,910
+8
| +0.1% | +$298 | 0.03% | 291 |
|
|
2022
Q4 | $555K | Buy |
15,902
+500
| +3% | +$17.5K | 0.03% | 391 |
|
|
2022
Q3 | $862K | Buy |
15,402
+1,323
| +9% | +$74K | 0.03% | 448 |
|
|
2022
Q2 | $730K | Buy |
14,079
+1,672
| +13% | +$86.7K | 0.03% | 558 |
|
|
2022
Q1 | $904K | Buy |
12,407
+6,977
| +128% | +$508K | 0.03% | 577 |
|
|
2021
Q4 | $643K | Sell |
5,430
-1,020
| -16% | -$121K | 0.02% | 615 |
|
|
2021
Q3 | $864K | Hold |
6,450
| – | – | 0.03% | 553 |
|
|
2021
Q2 | $1.05M | Buy |
+6,450
| New | +$1.05M | 0.03% | 499 |
|